Study Explores Real-World Rituximab Use in Rheumatoid Arthritis
In a long-term real-world study, researchers found that flare-based rituximab retreatment for rheumatoid arthritis maintained high drug retention but led to cycles of fluctuating disease activity and wellbeing.
